Sleep Profiler & PSG2

Sleep Profiler Psg Phillips Emg Model

News

As part of their commitment to continually improve the reporting capability of the PSG2 software, ABM has scheduled a significant portal update between 5 pm and midnight on Wednesday, April 3 (AEST)

Significant improvements are being added to the administration section of the portal – so while it will work all the same, everything should happen considerably faster. 

To help you plan your day, please note that the portal will be unavailable during this period as the updates are completed and tested. 

About

Introducing the Sleep Profiler PSG2 by Advanced Brain Monitoring – the cutting-edge solution for both clinical and research demands in sleep studies. Designed with versatility in mind, the Sleep Profiler PSG2 seamlessly caters to level 2 and 3 sleep studies, offering unparalleled insights into sleep patterns and disorders. Its advanced monitoring capabilities extend beyond traditional sleep analysis, making it an indispensable tool for diagnosing neurodegeneration and detecting ICU delirium and sepsis in hospital settings.

With its comprehensive features, robust scoring algorithms and precise data collection, the Sleep Profiler PSG2 stands at the forefront of innovation, empowering healthcare professionals with invaluable insights into patient care and research endeavours.

SYSTEM REVIEW
In-Home Patient-Applied Type 2 Home Sleep Test

Applications 

Clinical:

PSG2 enables clinicians to easily and accurately conduct unattended PSG studies to:

  • Rule out potential false negative Type III study results
  • Provide PSG studies to patients who are:
    • hospitalised and need to qualify for CAP reimbursement
    • in need based on co-morbidities, but unable to schedule a lab-based study
    • unable to sleep durina a laboratory PSG
    • suspected of upper airway resistance syndrome
    • suspected of having neurodegenerative disease.

Research:

PSG2 provides researcher the capability to assess the interaction between sleep architecture, hypoxemia, and sleeping position on sleep disordered breathing severity with variables that include:

  • REM and Non-REM apnea/hypopnea, apnea, and hypopnea indexes
  • Snoring above 30, 40, 50, and 60 dB by position
  • Number of hypopneas confirmed by arousals vs. desaturations by position
  • Number of apneas and hypopned events by position
  • 3% and 4% oxygen desaturation indexes by position.

The Sleep Profiler PSG2 combines the accuracy and versatility of the Sleep Profiler with the cardio-respiratory signals needed for a Type 2 unattended polysomnography study. This lightweight device includes voice messages and other intuitive design features that enable reliable self-application in the home with acquisition across multiple nights. 

The Sleep Profiler PSG2 can be used to detect sleep-disordered breathing such as:

  • Detection of apnoeas, hypopnea-desats, and hypopnea-arousals
  • Differentiation between obstructive and central apneas
  • Hypoxemic exposure during sleep
  • REM and positional influence on OSA severity
  • Frequency and intensity of positional snoring
  • Power spectral characteristics of the sleep stages.

The 13-channel system includes EEG, EOG and EMG, wireless oximetry, nasal pressure/airflow, chest and abdomen respiratory effort (RIP or piezo), forehead and finger pulse rate, head movement and position, and quantitative snoring. Sleep Profiler PSG2 is ideal for multi-night or repeated measures assessment.

Sleep Profiler PSG2 combines web-based presentation of recorded signals with validated auto-staging and technical editing capabilities to significantly reduce scoring time. The web-based software enables selection of either 3% or 4% desaturation criteria, with auto-scored apnoea/hypopnea indexes based on both AASM²⁰¹² and AASM²⁰⁰⁷ scoring rules and automated detection of poor signal quality. Interpretation features include customised editing, touchpoint insertion of key diagnostic and treatment recommendations, and secure signature insertion for quick and easy reporting. 

The Sleep Profiler PSG2 is the only home sleep apnoea test that uses voice messages to assist the patient to correctly self-apply the sensors. Real-time detection of poor airflow and oximetry signal quality trigger corrective voice alerts that contribute to an industry-leading 94% success rate for a Type 2 study. 

Specifications:

  • Channels – Up to 13
  • Power – Rechargeable Battery
  • Warranty – 2 years
  • Weight, including WristOx® and Effort Belts – up to 388g (13.7oz)
  • Memory – 8 GB internal
  • Recording Time – Up to 30 hours
  • Airflow range – ‡ 2cm H2O
  • Oximetry accuracy – ‡ 2% at one standard deviation from 70% to 100%.
In-Home Level 3 Sleep Testing

Applications 

Clinical:

Sleep Profiler enables clinicians to easily and accurately:

  • Differentiate short sleep syndrome from sleep state misperception
  • Identify abnormal sleep patterns attributed to chronic or neurodegenerative diseases
  • Monitor the effects of OSA therapy on sleep quality
  • Assess the dose-dependent medication effects on sleep architecture and sleep continuity.

Sleep Profiler is ideal for multi-night or repeated measures assessment of patients complaining of symptoms consistent with:

  • Insomnia
  • Hypersomnia
  • Other non-OSA sleep disorders.

Research:

Sleep Profiler is being used by researchers to assess:

  • REM sleep without Atonia in patients with RBD
  • Prodromal sleep biomarkers for neurodegenerative disease
  • Effect of Suvorexant progressive supranuclear palsy
  • Differences between normal cognition and mild cognitive impairment, Alzheimer’s disease, Parkinson’s Dementia, and
  • Dementia with Lewy Body
  • Sleep patterns in patients with ICU delirium
  • Effects of medication type, timing, and dosage on ICU sleep and outcomes
  • Sleep quality changes as a result of cannabis and opioid dependency
  • Outcomes resulting from an insomnia intervention
  • Influence of sleep deprivation on memory.

Sleep Profiler™ EEG Sleep Monitor bridges the gap between laboratory polysomnography and actigraphy. Three frontopolar channels provide the EEG, EOG and EMG signal features needed to characterise by-stage sleep time. This lightweight, wireless device includes voice messages and other intuitive design features that enable reliable self-application in the home with acquisition across multiple nights. 

Sleep Profiler is ideal for multi-night or repeated measures assessment of patients complaining of symptoms consistent with:

  • Insomnia
  • Hypersomnia
  • Other non-OSA sleep disorders.

Sleep Profiler combines web-based presentation of recorded signals with validated auto-staging and technical editing capabilities to significantly reduce scoring time. Interpretation features include customised editing, touchpoint insertion of key diagnostic and treatment recommendations, and secure signature insertion for quick and easy reporting. 

Report formats include automated generation of medical history summaries, medication usage, comparison to age/sex normative ranges, and patient reports that contrast their sleep diary entries to the objective sleep quality measures.

The new Sleep Profiler RTA software combines wireless transmission of the signals to a tablet with real-time sleep staging for the monitoring of sleep quality and abnormal EEG patterns in hospitalised patients or in research applications. 

Specifications:

  • Channels – Up to 8
  • Power – Rechargeable Battery
  • Warranty – 2 years
  • Dimensions – 7cm x 4.5cm x 1.75cm
  • Weight, Including Batteries – 71g (2.5oz)
  • Memory – 8 GB internal
  • Recording Time – Up to 30 hours.

Neurodegeneration Applications

The research team at ABM are currently using Sleep Profiler embark on groundbreaking studies to identify and track markers that will detect early signs of a range of neurodegenerative diseases. 

The ultimate aim is that this will become a standard test to identify if a patient is at risk of NDD. This will enable them to modify their lifestyle to reduce their risks or monitor the progression of the NDD. Early detection and identification of NDD is becoming more important than ever, as research into early stage treatments continue.

You can read more about the research into the early detection of NDD below: 

  1. Comparison of Sleep and Wake EEG Biomarkers in Mild Cognitive Impairment and Alzheimer’s Disease Dementia.
  2. Non-REM sleep with hypertonia in Parkinsonian Spectrum Disorders: A pilot investigation.
  3. Newly discovered sleep biomarkers pave the way for early detection of Parkinson’s disease, Alzheimer’s disease, Lewy body dementia, and other neurodegenerative diseases
  4. Effects of deep sedation on sleep in critically ill medical patients on mechanical ventilation.
  5. Investigation of Sleep Metrics in the Characterization of Neurodegenerative Diseases.
more research papers

ICU Sepsis and Delirium Detection Applications

Sleep Profiler RTA (Real Time Analysis)
Sleep in the ICU and Sleep post discharge has widely been reported as problematic. 24hr lighting, noise and staff disturbing patients for observations during the night disrupt normal Circadian Rhythms. Increasingly ICU’s and critical care facilities aim to maintain as normal circadian rhythm as possible.

Sleep Profiler RTA offers real-time sleep staging and unique algorithms for detecting abnormal EEG BioMarkers such as Sepsis and Delirium in acute patients. The high-quality EMG is also identified for the first time that 15-20% of

ICU patients experience never-before-seen ventilator-induced arousals.
The Sleep Profiler’s advanced algorithms have taken more than 10 years of development. Conventional Sleep EEG analysis results in large amount of incorrect staging and would miss most of the abnormal biomarkers the Sleep Profiler RTA identifies.

The Sleep Profiler RTA clearly shows when a patient is in deep sleep. where disturbances could be minimised during the night.

The Atypical N3 (non REM, deep sleep) is clearly identified to alert clinical staff  for possible Sepsis and Delirium.

The real time data is transmitted to a tablet and can be used in combination with the normal retro analysis of the Sleep Study using any combination of channels.
The Sleep Profiler RTA is currently in use in multi-centre ICU studies to further expand groundbreaking research in this area and is immediately available for clinical or research use.

ICU Research papers Sleep Position NDD Study

Training

TRAINING RESOURCES

Marketing

MARKETING RESOURCES

Warranty

Please follow this link to access the warranty claim procedures documents

Service Warranty Form

To make a warranty claim or send a device for service, complete the Service Form and follow the instructions on the form for next steps. If in doubt, contact your rep for troubleshooting.

The Sleep Profiler and PSG2 devices have a twenty-four (24) month warranty for electronic components enclosed within the serialised device, and b) twelve (12) months for replacement components (e.g. battery(s), removable memory card within the enclosure.

FAQs

Does the PSG2 meet the Medicare requirements for a level 2 sleep study in Australia?

The measures required during Home Sleep Test for 12250:

  • Airflow
  • Continuous EMG
  • Continuous ECG
  • Continuous EEG
  • EOG
  • Oxygen saturation
  • Respiratory effort
  • Other signals normally included: Body position, movement, snore sound, light.
Can patients apply the devices themselves at home?

Yes, patients can apply the device at home with.  The auditory alerts make it easy for patients to check for correct application prior to going to bed to ensure a successful study. 

Can you do multi-night studies with the device?
Yes, the device is well suited for multi-night studies with a rechargeable battery that lasts approx three nights on a single charge. You can also provide the patient with an external  battery to charge the device between nights for longer studies.
Image (1)
How do you clean the device between uses?

See page 11 of the manual for detailed cleaning instructions.

PSG2 Manual
What is the expected service life of the device?

PSG2 device (including airflow adapter) has an expected service life of five years. The sensor strip, battery, headband, sensors, and cannulas are considered replaceable components and are expected to be replaced during the service life of the device.

The sensor strip has an expected service life of 25 studies (50 nights). The battery has an expected service life of two years, which can be compromised by leaving the device on a charger for extended periods when the battery is fully charged. The headband does not have an expected service life, but is recommended to be replaced after 25-50 nights.

What are the computer requirements to use the Sleep Profiler Portal?

Computer Requirements:

  • Operating System: Microsoft Windows 8, 10, and Mac OS
  • JAVA: Latest release
  • USB 2.0 Port: 1
  • High Speed Internet Connection
  • Web Browser: Firefox, Internet Explorer (version 9 or newer), Google Chrome, Edge and Safari
  • 2GB RAM
  • Required Disk Space: Approximately 8 one night studies can be stored per GB.
  • Active and up-to-date anti-virus software and firewalls installed on computers connecting to the portal.
  • USB read/write access
  • PDF viewer.
What are the tablet spec requirements for use with the RTA software?

We recommend purchasing a high-quality tablet that contains at least: 

  • Bluetooth version 5.0 
  • an octo-core processor 
  • 4GB RAM

Research

PSG2 STUDIES & PUBLICATIONS
Back to product resources